Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nucala
Pharma
AZ's Fasenra flunks COPD trial as Saphnelo makes grade in lupus
After another swing and a miss for AstraZeneca's Fasenra in COPD, the company will prioritize other candidates for the indication.
Kevin Dunleavy
Sep 17, 2025 11:47am
GSK holds to its £40B projection for 2031, despite Blenrep woes
Jul 30, 2025 11:05am
GSK revs up launch plans after Nucala's FDA approval in COPD
May 22, 2025 3:10pm
FDA misses target date for GSK's Nucala in COPD
May 8, 2025 1:39pm
In battle with GSK's Nucala, AZ's Fasenra wins FDA nod for EGPA
Sep 18, 2024 11:46am
GSK posts COPD win for Nucala as rival nears possible approval
Sep 6, 2024 9:40am
